Login / Signup

Myeloid-specific dopamine D2 receptor signalling controls inflammation in acute pancreatitis via inhibiting M1 macrophage.

Xiao HanJianbo NiZengkai WuJianghong WuBin LiXin YeJuanjuan DaiCongying ChenJing XueRong WanLi WenXingpeng WangGuoyong Hu
Published in: British journal of pharmacology (2020)
Our data for the first time showed that myeloid-specific D2 receptor signalling controls pancreatic injury and systemic inflammation via inhibiting M1 macrophage, suggesting D2 receptor activation might serve as therapeutic target for AP.
Keyphrases
  • signaling pathway
  • dendritic cells
  • bone marrow
  • adipose tissue
  • acute myeloid leukemia
  • oxidative stress
  • transcription factor
  • electronic health record
  • big data
  • artificial intelligence
  • data analysis